Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Viatris Inc (NQ: VTRS ) 11.45 -0.17 (-1.46%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Viatris Inc < Previous 1 2 ... 6 7 8 9 10 11 12 13 Next > Oyster Point Pharma (NASDAQ: OYST) Enters Into Agreement to be Acquired by Viatris (NASDAQ: VTRS) For $11 Per Share Plus CVR Up to $2.00 Per Share November 07, 2022 Oyster Point Pharma, Inc. (NASDAQ: OYST) is engaged as a commercial-stage biopharmaceutical company, which is focused on the research, development Via Spotlight Growth Viatris Bolsters Its Ophthalmology Franchise With Oyster Point Pharma Deal, Shares Surge November 07, 2022 Via Benzinga IAA Stock Moves as Ritchie Bros Acquires Company in $7.3 Billion Deal November 07, 2022 IAA (IAA) stock is moving on Monday thanks to a massive acquisition $7.3 billion deal with Ritchie Bros Auctioneers (RBA). Via InvestorPlace Why Viatris Shares Are Soaring Higher November 07, 2022 Viatris Inc (NASDAQ: VTRS) shares are trading higher by 16.80% to $11.33 Monday morning after the company announced it will acquire Oyster Point Pharma. What Happened? Via Benzinga Viatris (VTRS) Stock Pops 17% on Acquisition News November 07, 2022 One press release with numerous positive catalysts is prompting some VTRS stock traders to load up on the shares today. Via InvestorPlace Viatris' Mylan Recalls One Lot Of Octreotide Acetate Injection Due To Glass Particulates October 26, 2022 Via Benzinga Viatris: Q2 Earnings Insights August 08, 2022 Viatris (NASDAQ:VTRS) reported its Q2 earnings results on Monday, August 8, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Via Benzinga What Does Sunshine Biopharma's Acquisition Of Nora Pharma Mean For The Generic Prescription Drugs Market? November 07, 2022 The generic drug market has been growing since 1984 when the Hatch-Waxman Act encouraged manufacturing generics and developed a framework to regulate them. Via Benzinga Cramer On This Stock Up 138% Year-To-Date: 'Santa Can't Afford That Coal, It's Going Up Too Much' November 07, 2022 On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended buying Cano Health Inc (NYSE: CANO). Via Benzinga Oyster Point Pharma, a Leading Ophthalmology-Focused Biopharmaceutical Company, to be Acquired by Viatris November 07, 2022 From Oyster Point Pharma, Inc. Via GlobeNewswire Recap: Viatris Q3 Earnings November 07, 2022 Viatris (NASDAQ:VTRS) reported its Q3 earnings results on Monday, November 7, 2022 at 06:50 AM. Here's what investors need to know about the announcement. Earnings Viatris beat estimated earnings by... Via Benzinga Earnings Scheduled For November 7, 2022 November 07, 2022 Companies Reporting Before The Bell • NAPCO Security Techs (NASDAQ:NSSC) is expected to report quarterly earnings at $0.13 per share on revenue of $36.34 million. Via Benzinga How To Attend Viatris Q3 2022 Earnings Conference Call November 01, 2022 Viatris (NASDAQ:VTRS) will host a conference call at 08:30 AM ET on November 7, 2022, to discuss Q3 2022 earnings results. How to Attend Viatris (VTRS) Conference Call Follow this link to access the... Via Benzinga 3 Feel-Good Ways to Lose Lots of Money in the Bear Market October 26, 2022 All three are liable to happen when you lose your focus on investing for the long term. Via The Motley Fool Recent Stock Purchase Update For October 2022 October 24, 2022 As you may know by now, I make a stock purchase every single month no matter what is going on in the world and despite the doom and gloom headlines. Let's take a look at what I've added to my portfolio... Via Talk Markets 3 Healthcare Stocks That Are Too Cheap to Ignore October 22, 2022 They all offer attractive dividends, too. Via The Motley Fool 3 Dirt-Cheap Stocks to Buy Sooner Rather Than Later October 22, 2022 Procrastination could be problematic with these three bargain stocks. Via The Motley Fool Novartis Fails To Prevent Generic Competition For Its Blockbuster Multiple Sclerosis Drug October 14, 2022 The U.S. Supreme Court rejected Novartis AG's (NYSE: NVS) effort to block the launch of generic versions of its multiple sclerosis drug Gilenya. Via Benzinga US Supreme Court Turns Away Biogen's Last Effort To Reinstate Tecfidera Patent October 03, 2022 The U.S. Supreme Court decided not to hear the case related to reinstating the patent of Biogen Inc's (NASDAQ: BIIB) blockbuster drug Tecfidera. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For October 21, 2022 October 21, 2022 Upgrades Via Benzinga Merck Stock Surges After Winning Patent Battle Vs. Viatris Over Two Key Drugs September 22, 2022 The decision affects two of Merck's best-selling drugs. Via Investor's Business Daily Recent Stock Purchase September 2022 September 19, 2022 I make a stock purchase every single month no matter what is going on in the world and despite the doom and gloom headlines. Via Talk Markets Stocks That Hit 52-Week Lows On Thursday September 22, 2022 On Thursday, 1076 companies hit new 52-week lows. Via Benzinga 7 Screaming Buy Stock Picks to Beat the September Market Slump September 13, 2022 Savvy investors can use these stock picks to beat the market and take advantage of market weakness and panic selling. Via InvestorPlace Stocks That Hit 52-Week Lows On Tuesday September 20, 2022 On Tuesday, 507 stocks hit new 52-week lows. Via Benzinga September 2022 Stock Considerations September 08, 2022 Let’s take a look at my September stock considerations which are similar to recent considerations from one to four months ago. Via Talk Markets Is Viatris Inc. a Contrarian Dividend Option for Your Portfolio? September 03, 2022 Does kicking against market trends make you even more excited about investing? If so, you may want to consider drugmaker Viatris Inc. (NASDAQ: VTRS), which produces products that treat diabetes,... Via MarketBeat Stocks That Hit 52-Week Lows On Monday September 19, 2022 On Monday, 429 stocks made new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Thursday September 01, 2022 On Thursday, 529 companies set new 52-week lows. Via Benzinga This Company Reports Its Consumer Therapeutics Could Be A Game Changer For People With Skin Problems August 24, 2022 From allergies and insect bites to sunburns and irritations, the human skin can succumb to several conditions, including acne, psoriasis, blisters, hives, actinic keratosis, rosacea, and carbuncle. Via Benzinga < Previous 1 2 ... 6 7 8 9 10 11 12 13 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
